Skip to content

Insider · CIK 0002000632

Neal Pawar

cooofficer

Files at ENFN (Enfusion, Inc.). First filing Dec 2, 2024, latest Mar 7, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $872k sold

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
46Moderate
ENFNsell 6
Enfusion, Inc.
$166k
14,560 shares
-1%-
40Moderate
ENFNsell 6
Enfusion, Inc.
$32k
2,769 shares
-0%-
38Weak
ENFNsell
Enfusion, Inc.
$483k
48,047 shares
-4%-
32Weak
ENFNsell
Enfusion, Inc.
$191k
19,226 shares
-2%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Apr 21, 2025ENFN
Enfusion, Inc.
DDisposition to issuer
Class A Common Stock
-135,613--1,081,695Apr 21, 2025
Apr 21, 2025ENFN
Enfusion, Inc.
DDisposition to issuer
Class A Common Stock
-501,695--580,000Apr 21, 2025
Apr 21, 2025ENFN
Enfusion, Inc.
DDisposition to issuer
Class A Common Stock
-580,000--0Apr 21, 2025
Mar 5, 2025ENFN
Enfusion, Inc.
SOpen-market sale
Class A Common Stock
-14,560$11.38$166k1,217,067Mar 7, 2025
Mar 3, 2025ENFN
Enfusion, Inc.
SOpen-market sale
Class A Common Stock
-2,769$11.48$32k1,231,627Mar 5, 2025
Feb 26, 2025ENFN
Enfusion, Inc.
AGrant or award
Class A Common Stock
+110,230$0.00$01,227,528Feb 28, 2025
Feb 26, 2025ENFN
Enfusion, Inc.
AGrant or award
Class A Common Stock
+6,868$0.00$01,234,396Feb 28, 2025
Dec 2, 2024ENFN
Enfusion, Inc.
SOpen-market sale
Class A Common Stock
-21,801$10.03$219k1,143,544Dec 4, 2024
Dec 3, 2024ENFN
Enfusion, Inc.
SOpen-market sale
Class A Common Stock
-26,246$10.09$265k1,117,298Dec 4, 2024
Nov 29, 2024ENFN
Enfusion, Inc.
SOpen-market sale
Class A Common Stock
-19,226$9.92$191k1,165,345Dec 2, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Neal Pawar: insider trades and track record | InsiderTell